文献速递腹部CT

多排CT预测结肠癌组织病理学:按肿瘤侧别和微卫星状态分层的全国登记研究

Prediction of histopathology in colon cancer by multidetector computed tomography stratified by tumour side and microsatellite status: A national register study.
PubMed 文献 · Eur J Radiol · 2025-07-18

基于丹麦结直肠癌组2015至2022年14455例原发性结肠腺癌切除患者的前瞻性登记数据,回顾性分析多排CT预测pT分期、区域淋巴结转移和局部进展期疾病的准确性,并按肿瘤部位及微卫星不稳定状态分层。结果显示多排CT对pT3-T4低估率约55%至57%,对局部进展期疾病过度分期率约33%至40%,作者结论认为多排CT用于结肠癌临床分期存在关键局限性,基于其的治疗决策有临床显著过度或不足治疗的风险。

要点

  • 多排CT预测pT3-T4的阴性预测值右侧0.43、左侧0.45,分别有57%和55%的病例被低估。
  • 多排CT预测区域淋巴结转移的阳性预测值右侧0.47、左侧0.50。
  • 多排CT预测局部进展期疾病的敏感度两侧均为0.56,阳性预测值右侧0.62、左侧0.67。

核心结论

  • 多排CT用于结肠癌T分期、区域淋巴结转移和局部进展期疾病的临床分期存在关键局限性,基于其的治疗决策有临床显著过度或不足治疗的风险。

研究设计与样本

  • 回顾性、基于人群的登记研究,利用丹麦结直肠癌组前瞻性记录的数据,纳入2015至2022年间因原发性结肠腺癌接受切除的14455例患者,样本量由DCCG数据库中可用病例确定,试验注册号Danish Colorectal Cancer Database #DCCG_2023_02_24。

诊断标准与关键数值

  • 预测pT3-T4肿瘤:多排CT阴性预测值右侧0.43、左侧0.45,低估率分别为57%和55%;阳性预测值两侧相似,均为91%。
  • 按微卫星状态分层预测pT3-T4肿瘤:MSI肿瘤阴性预测值0.47,MSS肿瘤阴性预测值0.40。
  • 预测区域淋巴结转移(pN1-2):阳性预测值右侧0.47、左侧0.50;右侧结肠癌中MSI肿瘤阴性预测值0.56,MSS肿瘤阴性预测值0.72。
  • 预测局部进展期疾病:敏感度两侧均为0.56;阳性预测值右侧0.62、左侧0.67,过度分期率分别为38%和33%。
  • 按微卫星状态分层预测局部进展期疾病:MSI肿瘤阳性预测值0.60,MSS肿瘤阳性预测值0.65,过度分期率分别为40%和35%。

临床应用与阅片要点

  • 作者结论指出,临床医生必须意识到基于多排CT的治疗决策存在临床显著过度治疗或不足治疗的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Multidetector computed tomography (MDCT) is widely used for colon cancer staging, although it has known limitations. This study evaluates the accuracy of MDCT in predicting the T category, regional lymph node metastases, and locally advanced disease. We stratified these predictions by tumour location, right-sided versus left-sided colon cancers, and, within right-sided colon cancers, further analysed them based by microsatellite instability status.

METHODS: A retrospective, population-based register study, utilising prospectively recorded data from the Danish Colorectal Cancer Group, on 14,455 patients undergoing resection for primary colon adenocarcinoma between 2015 and 2022. The sample size was determined by cases available in the DCCG database.

RESULTS: To predict pT3-T4 tumours, MDCT showed NPVs of 0.43 (right-sided) and 0.45 (left-sided), with 57% and 55% understaged, respectively; PPVs were a similar 91%. For MSI and MSS tumours, NPVs were 0.47 and 0.40, respectively. For lymph node metastases (pN1-2), PPVs were 0.47 (right-sided) and 0.50 (left-sided). NPVs for MSI and MSS right-sided cancers were 0.56 and 0.72, respectively. Sensitivity for locally advanced disease was 0.56 for both sides. PPVs were 0.62 (right-sided) and 0.67 (left-sided), resulting in 38% and 33% overstaged, respectively. For MSI and MSS tumours, PPVs were 0.60 and 0.65, with 40% and 35% overstaged, respectively.

CONCLUSIONS: Multidetector computed tomography for clinical staging in colon cancer regarding T category, regional lymph node metastases, and locally advanced disease has critical limitations. Clinicians must be aware that treatment decisions based on MDCT carry a risk clinically significant over- or undertreatment.

TRIAL REGISTRATION: Danish Colorectal Cancer Database (#DCCG_2023_02_24).

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Casarin G, Fattori S, Andersen TH, et al. Prediction of histopathology in colon cancer by multidetector computed tomography stratified by tumour side and microsatellite status: A national register study. Eur J Radiol. 2025. PMID: 40706416. doi:10.1016/j.ejrad.2025.112329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。